Pegylated TNF inhibitor 'effective' in refractory RA

21 November 2008 Print this article Comments Share this article
Investigators report a rapid and sustained clinical improvement in rheumatoid arthritis (RA) signs and symptoms when treated with a phase III long-acting pegylated TNF inhibitor....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites